Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Divestments (2018)

Pharma-Bio Serv's Divestments history spans 1 years, with the latest figure at $2.0 million for Q4 2018.

  • For Q4 2018, Divestments changed N/A year-over-year to $2.0 million; the TTM value through Jul 2019 reached $2.0 million, changed N/A, while the annual FY2018 figure was $2.0 million, 606.67% up from the prior year.
  • Divestments reached $2.0 million in Q4 2018 per PBSV's latest filing.
  • In the past five years, Divestments ranged from a high of $2.0 million in Q4 2018 to a low of $2.0 million in Q4 2018.